Literature DB >> 22498828

Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.

Isabelle Auquit-Auckbur1, Câlin Lazar, Sophie Deneuve, Cécile Guillemet, Nadège Cordel, France Blanchard, Pascal Joly, Philippe Courville.   

Abstract

Mastocytosis is a group of disorders characterized by abnormal mast cell proliferation, involving the skin in 80% of cases. Cutaneous mastocytosis, which appears in childhood in 60% of cases, usually has a benign course with a gradually regressive evolution before puberty. Mast cell sarcomas, part of the systemic forms of mastocytosis, are very rare tumors characterized by a destructive growth of highly atypical mast cells, with secondary spread, poor prognosis, and low survival rates. We report the first known case of primary cutaneous mast cell sarcoma due to the transformation of a benign solitary mastocytoma in an adult suffering from an unregressive localized cutaneous mastocytosis. Histologic characteristics of the tumor, mutation analysis, and c-Kit expression were compared with available data. Wide surgical excision of the tumor followed by adjuvant local radiotherapy were performed, and for the first time the use of imatinib was attempted, as neoplastic mast cells expressed the CD117 marker. However, they failed to control the progression of sarcoma. To date, no treatment is known to be effective for this disease, which is associated with short-term survival of the patients.

Entities:  

Mesh:

Year:  2012        PMID: 22498828     DOI: 10.1097/PAS.0b013e31824c0d92

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

Review 1.  Mast Cell Activation Syndrome.

Authors:  Marianne Frieri
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

2.  Mast cell sarcoma of the sternum, clonally related to an antecedent germ cell tumor with a novel D579del KIT mutation.

Authors:  Atsushi Yamashita; Tsuyoshi Saito; Keisuke Akaike; Atsushi Arakawa; Akihiko Yoshida; Kentaro Kikuchi; Masahiko Sugitani; Takashi Yao
Journal:  Virchows Arch       Date:  2017-02-24       Impact factor: 4.064

Review 3.  Childhood Solitary Cutaneous Mastocytoma: Clinical Manifestations, Diagnosis, Evaluation, and Management.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong
Journal:  Curr Pediatr Rev       Date:  2019

4.  Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.

Authors:  Iván Alvarez-Twose; Almudena Matito; José Mário Morgado; Laura Sánchez-Muñoz; María Jara-Acevedo; Andrés García-Montero; Andrea Mayado; Carolina Caldas; Cristina Teodósio; Javier Ignacio Muñoz-González; Manuela Mollejo; Luis Escribano; Alberto Orfao
Journal:  Oncotarget       Date:  2016-07-19

Review 5.  Mast cell sarcoma: new cases and literature review.

Authors:  Jilliana Monnier; Sophie Georgin-Lavialle; Danielle Canioni; Ludovic Lhermitte; Michael Soussan; Michel Arock; Julie Bruneau; Patrice Dubreuil; Christine Bodemer; Marie-Olivia Chandesris; Olivier Lortholary; Olivier Hermine; Gandhi Damaj
Journal:  Oncotarget       Date:  2016-10-04

6.  Case report of a clinically indolent but morphologically high-grade cutaneous mast cell tumor in an adult: Atypical cutaneous mastocytoma or mast cell sarcoma?

Authors:  Claire L W Wardle; J Marja Oldhoff; Arjan Diepstra; Peter Valent; Hans-Peter Horny; Hanneke N G Oude Elberink; Philip M Kluin; Gilles F H Diercks
Journal:  J Cutan Pathol       Date:  2021-07-02       Impact factor: 1.587

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.